Literature DB >> 25464112

Involved field irradiation for the treatment of esophageal cancer: is it better than elective nodal irradiation?

Liyang Jiang1, Xin Zhao2, Xue Meng1, Jinming Yu3.   

Abstract

Esophageal cancer (EC) is an extremely aggressive and lethal malignancy with an increasing incidence worldwide. Currently, the combination of radiotherapy and concurrent chemotherapy is performed for nonsurgical EC. However, there is no clear consensus on the accurate definition of the clinical target volume. Still, elective nodal irradiation (ENI) is the conventional remedy adopted for EC patients, while severe radiotherapy-related toxicities would occur in at least half of patients. Involved field irradiation (IFI) is a selective way to decrease the irradiation volume and thereby to decline toxicities. This review centers on the modality of IFI and compares the treatment efficacy between IFI and ENI.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Elective nodal irradiation; Esophageal cancer; Involved field irradiation

Mesh:

Year:  2014        PMID: 25464112     DOI: 10.1016/j.canlet.2014.11.045

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  12 in total

1.  Activin A expression in esophageal carcinoma and its association with tumor aggressiveness and differentiation.

Authors:  Zhenhua Wang; Ning Zhang; Ruifeng Song; Ruitai Fan; Liuqin Yang; Liping Wu
Journal:  Oncol Lett       Date:  2015-05-20       Impact factor: 2.967

Review 2.  Assessing the interactions between radiotherapy and antitumour immunity.

Authors:  Clemens Grassberger; Susannah G Ellsworth; Moses Q Wilks; Florence K Keane; Jay S Loeffler
Journal:  Nat Rev Clin Oncol       Date:  2019-06-26       Impact factor: 66.675

3.  Long-term outcome of concurrent chemoradiotherapy with elective nodal irradiation for inoperable esophageal cancer.

Authors:  Zhao Jing; Tian Chen; Xuebang Zhang; Shixiu Wu
Journal:  Cancer Sci       Date:  2017-07-27       Impact factor: 6.716

4.  The prognostic and clinicopathologic characteristics of CD147 and esophagus cancer: A meta-analysis.

Authors:  Hui Li; Chunxiang Jiang; Dongwen Wu; Shupeng Shi; Mengting Liao; Jing Wang; Yanwen Li; Zihao Xu
Journal:  PLoS One       Date:  2017-07-11       Impact factor: 3.240

5.  Patterns of failure and clinical outcomes of definitive radiotherapy for cervical esophageal cancer.

Authors:  Lina Zhao; Yongchun Zhou; Yunfeng Mu; Guangjin Chai; Feng Xiao; Lina Tan; Steven H Lin; Mei Shi
Journal:  Oncotarget       Date:  2017-03-28

6.  A chalcone inhibits the growth and metastasis of KYSE-4 esophageal cancer cells.

Authors:  Jie Chen; Chun-Yan Kang; Zhao-Xia Niu; Hui-Cong Zhou; Hong-Mei Yang
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

7.  Elective nodal irradiation provides a superior therapeutic modality for lymph node positivity esophageal squamous cell carcinoma patients receiving definitive radiotherapy versus involved-field irradiation.

Authors:  Qiaofang Li; Shuchai Zhu; Shuguang Li; Wenzhao Deng
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

Review 8.  What Is the Appropriate Clinical Target Volume for Esophageal Squamous Cell Carcinoma? Debate and Consensus Based on Pathological and Clinical Outcomes.

Authors:  Dali Han; Yinping Yuan; Xuqing Song; Yonghua Yu; Jinming Yu
Journal:  J Cancer       Date:  2016-01-01       Impact factor: 4.207

9.  Treatment of esophageal cancer with radiation therapy -a pan-Chinese survey of radiation oncologists.

Authors:  Yun Zhang; Jing Liu; Wencheng Zhang; Weiye Deng; Jinbo Yue
Journal:  Oncotarget       Date:  2017-05-23

10.  Photon Versus Proton Beam Therapy for T1-3 Squamous Cell Carcinoma of the Thoracic Esophagus Without Lymph Node Metastasis.

Authors:  Yang-Gun Suh; Unurjargal Bayasgalan; Heung Tae Kim; Jong Mog Lee; Moon Soo Kim; Youngjoo Lee; Doo Yeul Lee; Sung Uk Lee; Tae Hyun Kim; Sung Ho Moon
Journal:  Front Oncol       Date:  2021-06-21       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.